Gainers
- Kineta KA shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million.
- iSpecimen ISPC stock moved upwards by 13.99% to $0.57. The market value of their outstanding shares is at $5.6 million.
- ENDRA Life Sciences NDRA shares moved upwards by 11.0% to $0.12. The market value of their outstanding shares is at $1.9 million.
- Brainstorm Cell BCLI shares increased by 9.08% to $0.51. The market value of their outstanding shares is at $35.9 million.
- Bullfrog AI Hldgs BFRG stock increased by 7.53% to $2.71. The company's market cap stands at $21.2 million.
- Can Fite Biofarma CANF stock increased by 7.46% to $3.6. The company's market cap stands at $17.9 million.
Losers
- Nexalin Technology NXL stock decreased by 12.4% to $0.78 during Friday's after-market session. The market value of their outstanding shares is at $5.8 million.
- Scinai Immunotherapeutics SCNI shares fell 11.47% to $3.09. The market value of their outstanding shares is at $1.7 million.
- Ontrak OTRK stock declined by 7.45% to $0.23. The company's market cap stands at $11.0 million.
- AN2 Therapeutics ANTX stock declined by 7.38% to $2.01. The company's market cap stands at $59.9 million.
- CERo Therapeutics Hldgs CERO shares decreased by 6.03% to $0.36. The company's market cap stands at $5.3 million.
- Renovaro RENB stock decreased by 5.49% to $1.55. The company's market cap stands at $228.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BCLIBrainstorm Cell Therapeutics Inc
$2.20-4.35%
BFRGBullfrog AI Holdings Inc
$2.558.97%
CANFCan Fite Biofarma Ltd
$1.54-2.53%
CEROCERo Therapeutics Holdings Inc
$2.30-0.43%
ISPCiSpecimen Inc
$2.28-5.20%
NDRAENDRA Life Sciences Inc
$5.85-4.85%
NXLNexalin Technology Inc
$2.76-2.11%
OTRKOntrak Inc
$1.810.56%
RENBRenovaro Inc
$0.74704.49%
SCNIScinai Immunotherapeutics Ltd
$3.40-4.49%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in